Man Group PLC Bolt Biotherapeutics, Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.29 - $1.66 $1,145 - $1,474	888 Added 3.63%	25,367 $35,000
Q4 2022 Feb 14, 2023	BUY	$1.26 - $1.51 $8,290 - $9,935	6,580 Added 36.76%	24,479 $31,000
Q3 2022 Nov 14, 2022	BUY	$1.48 - $2.61 $94 - $167	64 Added 0.36%	17,899 $26,000
Q2 2022 Aug 15, 2022	BUY	$1.41 - $2.91 $25,147 - $51,899	17,835 New	17,835 $37,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $21.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.